Table 4.
Results of fitting a taxonomy of multiple survival regression models, February 2020 to March 2022.
| Hazard ratio (95% CI) |
||||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | |
| Indigenous (Comparison = Non-indigenous) |
1.67 *** (1.62, 1.72) |
1.24*** (1.20, 1.28) |
1.61*** (1.56, 1.67) |
1.12*** (1.09, 1.16) |
1.08*** (1.05, 1.11) |
1.08*** (1.04, 1.11) |
| Sex (Comparison = Female) |
1.55*** (1.54, 1.56) |
1.27*** (1.26, 1.28) |
1.27*** (1.26, 1.28) |
|||
| Age | 1.07*** (1.07, 1.07) |
1.03*** (1.03, 1.03) |
1.03*** (1.03, 1.03) |
|||
| Time in days from symptom onset to seeking care | 1.10*** (1.10, 1.10) |
0.99*** (0.99, 0.99) |
0.98*** (0.98, 0.98) |
- | ||
| Type of care (Comparison = Outpatient) |
59.67*** (58.71, 60.65) |
24.55*** (24.13, 24.99) |
- | |||
| 1-2 comorbidity (Comparison = No comorbidity) |
2.30*** (2.26, 2.34) |
2.28*** (2.25, 2.32) |
||||
| 3 or more comorbidity (Comparison = No comorbidity) |
2.96*** (2.91, 3.01) |
2.94*** (2.90, 2.99) |
||||
| (Type of care) * (time in days from symptom onset to seeking care) | ||||||
| Time in days from symptom onset to seeking care (for outpatients) |
1.07*** (1.06, 1.07) |
|||||
| Time in days from symptom onset to seeking care (for hospitalized) |
0.98*** (0.97, 0.98) |
|||||
| Type of care, when time from symptom onset to care=0 (Comparison = Outpatient) |
36.29*** (35.28, 37.33) |
|||||
| Akaike information criterion | 6,879,429.7 | 6,552,629.9 | 6,849,913.9 | 6,260,272.2 | 6,169,794.7 | 6,168,502.6 |
*P<0.05, **P<0.01, ***P<0.001
CI, confidence interval